SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-098142
Filing Date
2022-04-07
Accepted
2022-04-07 07:15:54
Documents
15
Period of Report
2022-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d301238d8k.htm   iXBRL 8-K 22952
2 EX-99.1 d301238dex991.htm EX-99.1 21894
6 GRAPHIC g301238g0407043246872.jpg GRAPHIC 4141
7 GRAPHIC g301238g0407043247232.jpg GRAPHIC 4665
  Complete submission text file 0001193125-22-098142.txt   189996

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20220407.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20220407_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20220407_pre.xml EX-101.PRE 11692
9 EXTRACTED XBRL INSTANCE DOCUMENT d301238d8k_htm.xml XML 3529
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 22812287
SIC: 2834 Pharmaceutical Preparations